home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Genetic Mutation In Familial Aortic Aneurysm

  November, 14 2007 19:08
your information resource in human molecular genetics
Mutations in a gene expressed in smooth muscle cells account for about 14% of cases of hereditary thoracic aortic aneurysm, reports a paper published online Nature Genetics. A thoracic aortic aneurysm is a widening of the wall of the aorta -- the body's largest artery -- and can lead to heart attack and stroke.

About one in five of all individuals affected by thoracic aortic aneurysms and dissections (TAAD) have a family history of the disorder, suggesting a genetic predisposition. Only two genes have been implicated in familial cases of TAAD so far, and they account for only about 5% of such cases. Dianna Milewicz and colleagues mapped the gene causing a novel form of TAAD in a large family, and identified mutations in ACTA2, encoding smooth muscle alpha-actin. Mutations in ACTA2 were also identified in individuals in 14 additional families affected by TAAD. Smooth muscle alpha-actin is the most abundant protein found in smooth muscle cells, which are required for contraction of the aorta and other blood vessels in the regulation of blood pressure and flow. One of the other proteins associated with TAAD, MYH11, interacts with ACTA2 in regulating smooth muscle cell contraction, and the authors suggest that this process must be critical in maintaining the structural integrity of the aorta. It is not known whether mutations in ACTA2 are involved in non-familial cases of TAAD.

Author contact:

Dianna Milewicz (University of Texas Health Science Center, Houston, TX, USA)
E-mail: dianna.m.milewicz@uth.tmc.edu

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.